StonvexLoading…
StonvexStonvexStonvexCore line items from ELUT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $3.11M | $12.29M | $9.02M | $12.29M |
Operating Income | $-6.35M | $-26.91M | $-20.35M | $-17.80M |
Net Income | $-7.47M | $53.38M | $-17.41M | $-13.54M |
EPS (Diluted) | $-0.17 | $0.87 | $-0.66 | $-0.47 |
Total Assets | $55.21M | $62.35M | $29.41M | $33.85M |
Total Liabilities | $32.68M | $34.68M | $73.33M | $75.69M |
Cash & Equivalents | $28.49M | $36.35M | $4.72M | $8.50M |
Free Cash Flow OCF − CapEx | $-8.29M | $-46.69M | $-21.02M | $-17.50M |
Shares Outstanding | 43.00M | 45.94M | 45.49M | 44.77M |